中华顶尖财经--信息搜索

信息搜索

信息关键字：医

『查询2022年信息』『查询2021年信息』『查询2020年信息』『查询2019年信息』『查询2018年信息』『查询2017年信息』『查询2016年信息』
『查询2015年信息』『查询2014年信息』『查询2013年信息』『查询2012年信息』『查询2011年信息』『查询2010年信息』『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]

·鲁抗医药：莫那比拉韦胶囊获得军队特需药品临床前研究立项批件2023-3-2 18:15:52

·捍宇医疗转战科创板：董事的丈夫举足轻重，所受制约却有限2023-3-2 17:40:31

·锦好医疗（872925）3月2日游资资金净买入37.09万元2023-3-2 17:36:07

·华厦眼科：医教研一体化眼科龙头，打造眼科学术高地2023-3-2 17:27:30

·“限抗令”加码河南全面取消医院门诊输液费2023-3-2 16:13:21

·互动|爱博医疗：“海肌理”是公司布局的消费类品牌之一2023-3-2 14:24:22

·生物基因科技公司优迅医学赴港IPO专家称基因检测市场有望持续高速增长2023-3-2 10:37:55

·大博医疗（002901）3月1日主力资金净卖出599.89万元2023-3-2 9:51:55

·智通元宇中小市值研究报告系列(2023年3月)：聚焦医疗等主线品种 ChatGPT等主题投资或吸引资本关注2023-3-2 8:48:09

·财闻点金：医疗信息化接连获重要政策文件支持2023-3-2 8:35:34

·医药板块：把握困境反转、产业趋势、业绩催化三类机会2023-3-2 0:30:41

·中瑞医药拟向银行申请不超过5.1亿综合授信董事长黄瑞杰及公司股东、董事衡燕提供保证担保2023-3-1 23:19:15

·易联众股东微医控股质押1540万股用于补充流动资金2023-3-1 20:11:06

·捍宇医疗科创板IPO获受理2023-3-1 19:54:17

·锦好医疗（872925）3月1日游资资金净买入32.45万元2023-3-1 18:16:38

·艾力斯：与和誉医药签署许可协议2023-3-1 18:12:09

·国家医保局：持续扩大药品集采覆盖面价格偏高的品种要持续挤压价格水分2023-3-1 17:26:35

·沃华医药（002107）3月1日主力资金净卖出971.06万元2023-3-1 15:50:36

·中医药振兴发展重大工程实施方案发布三大细分领域上市公司或直接受益2023-3-1 14:41:03

·3月新规来了！事关医保、食品和化妆品还有这个赚钱“新法子”2023-3-1 10:27:43

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]